STEVEN KAHN

SEATTLE, WA NPI 1104901800

General Payments — all program years on this page

$517,255.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 343
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $88,531.32 across 58 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Eli Lilly and Company $46,065.1443
Novo Nordisk AS $36,692.4313
Amgen Inc. $5,773.752

By program year

Program yearAmountRecords
2018 $144,953.8381
2019 $135,875.45115
2020 $32,033.5312
2021 $33,888.5211
2022 $45,399.3639
2023 $36,573.3027
2024 $88,531.3258

Records — PY2024 (58)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096551895 Novo Nordisk AS $164.11 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096552225 Novo Nordisk AS $321.59 11/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552351 Novo Nordisk AS $251.75 09/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096552381 Novo Nordisk AS $975.00 11/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1096552415 Novo Nordisk AS $9,955.00 09/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552423 Novo Nordisk AS $1,324.48 09/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552565 Novo Nordisk AS $975.00 04/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1096552671 Novo Nordisk AS $235.73 09/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552785 Novo Nordisk AS $409.14 11/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552885 Novo Nordisk AS $1,358.00 11/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096553065 Novo Nordisk AS $10,781.25 09/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096553303 Novo Nordisk AS $9,843.75 06/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096553325 Novo Nordisk AS $97.63 06/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117592800 Amgen Inc. $2,607.50 05/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117592802 Amgen Inc. $3,166.25 11/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135350774 Eli Lilly and Company $106.63 09/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135350776 Eli Lilly and Company $147.92 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135350778 Eli Lilly and Company $5.29 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135350780 Eli Lilly and Company $31.14 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135350782 Eli Lilly and Company $9,055.60 09/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135350784 Eli Lilly and Company $14.32 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135350786 Eli Lilly and Company $15.21 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135350788 Eli Lilly and Company $12.95 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135391773 Eli Lilly and Company $4.59 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135391775 Eli Lilly and Company $59.09 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135391777 Eli Lilly and Company $2.41 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135391779 Eli Lilly and Company $4.99 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135405626 Eli Lilly and Company $106.63 09/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135405628 Eli Lilly and Company $5.77 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135405630 Eli Lilly and Company $4.99 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135405632 Eli Lilly and Company $3.24 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135405634 Eli Lilly and Company $10,899.20 09/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135405636 Eli Lilly and Company $111.00 11/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135405638 Eli Lilly and Company $8,750.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135405640 Eli Lilly and Company $35.00 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135405642 Eli Lilly and Company $34.28 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135417137 Eli Lilly and Company $2,064.40 09/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135417139 Eli Lilly and Company $3.24 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135417141 Eli Lilly and Company $5,000.00 03/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135417143 Eli Lilly and Company $632.58 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135417145 Eli Lilly and Company $144.18 10/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135417147 Eli Lilly and Company $22.78 11/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135417149 Eli Lilly and Company $179.00 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135421153 Eli Lilly and Company $110.24 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135421155 Eli Lilly and Company $64.35 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135421157 Eli Lilly and Company $5.29 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135428224 Eli Lilly and Company $11.49 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135428226 Eli Lilly and Company $9.99 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135428228 Eli Lilly and Company $185.00 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135432861 Eli Lilly and Company $8.56 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135432863 Eli Lilly and Company $85.50 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135432865 Eli Lilly and Company $6.64 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135432867 Eli Lilly and Company $136.53 03/21/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135432869 Eli Lilly and Company $7,500.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135433863 Eli Lilly and Company $347.17 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135433865 Eli Lilly and Company $74.27 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135433867 Eli Lilly and Company $59.09 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135433869 Eli Lilly and Company $4.59 11/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.